DE KLUIS
DE KLUIS is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show negative equity (€-103k) and a net result of €-204k. Equity is shrinking by ~100.1% per year across the filed fiscal years. Its solvency ranks better than 5% of 514 sector peers (fiscal year 2025). The company has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-103k |
| Net result | €-204k |
| Better than sector | 5% |
| Active | 28 yrs |
Strong profile, led by profitability.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -289.2% | 43.7% | |
| Net result | €-204k | €67k | |
| Equity | €-103k | €506k | |
| Gross operating margin | €94k | €81k | |
| Total assets | €36k | €1.61M |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Deposit | abbreviated schema | abbreviated schema | abbreviated schema |
| Revenue | n/a | n/a | n/a |
| EBITDA | n/a | n/a | n/a |
| Net profit | €-204k | €2k | €-9k |
| Cash flow | n/a | n/a | n/a |
| Staff costs | - | - | - |
| Income taxes | €16k | €523 | €203 |
| Dividends | - | - | - |
| Total assets | €36k | €323k | €322k |
| Equity | €-103k | €101k | €99k |
| Debt | €139k | €222k | €223k |
| of which ≤ 1y | €137k | €220k | €221k |
| of which > 1y | - | - | - |
| Working capital | n/a | n/a | n/a |
| Employees (FTE) | - | - | - |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | n/a | n/a | n/a |
| Quick ratio | n/a | n/a | n/a |
| Working capital ratio | n/a | n/a | n/a |
| Solvency | -289.2% | 31.3% | 30.8% |
| Debt / equity | n/a | n/a | n/a |
| Long-term debt ratio | n/a | n/a | n/a |
| Interest coverage | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a |
| ROA | -572.2% | 0.6% | -2.9% |
| ROE | 197.9% | 2.0% | -9.4% |
| EBITDA margin | n/a | n/a | n/a |
| Days sales outstanding | n/a | n/a | n/a |
| Days payable outstanding | n/a | n/a | n/a |
| Inventory turnover | n/a | n/a | n/a |
| Days inventory (DSI) | n/a | n/a | n/a |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €36k | €323k | €322k |
| Fixed assets | 21/28 | €4k | €318k | €318k |
| Tangible fixed assets | 22/27 | €4k | - | - |
| Financial fixed assets | 28 | - | €318k | €318k |
| Current assets | 29/58 | €32k | €5k | €5k |
| Amounts receivable within one year | 40/41 | €14k | €4k | €252 |
| Cash & bank | 54/58 | €12k | €550 | €3k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €36k | €323k | €322k |
| Equity | 10/15 | €-103k | €101k | €99k |
| Contributions / capital | 10/11 | €43k | €43k | €43k |
| Reserves | 13 | €56k | €56k | €54k |
| Accumulated profits (losses) | 14 | €-203k | €2k | €2k |
| Amounts payable | 17/49 | €139k | €222k | €223k |
| Amounts payable within one year | 42/48 | €137k | €220k | €221k |
| Trade debts payable within one year | 44 | €4k | €1k | €6k |
| Income statement | ||||
| Gross operating margin | 9900 | €94k | €7k | €-7k |
| Operating result | 9901 | €92k | €5k | €-9k |
| Financial income | 75 | €369 | - | - |
| Financial charges | 65 | €3k | €2k | €609 |
| Result before taxes | 9903 | €-188k | €3k | €-9k |
| Income taxes | 67/77 | €16k | €523 | €203 |
| Net result for the period | 9904 | €-204k | €2k | €-9k |
| Result to be appropriated | 9905 | €-204k | €2k | €-9k |
| NACE primary | Activities of holding companies(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 17-03-1998 |
| Status | Active |
| Postal code | 2018 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11810K1515/00G011 | Flanders | 172 m² | 1 · 83 m² | 12.0 m · 3 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
09-07-2025 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "fusion_share_issue",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Bart Van Tulden",
"firm_city": null,
"firm_name": null,
"office_city": "Antwerpen",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-07-09",
"filing_date": "2025-06-30",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-30",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-06-16"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0462.891.621",
"name_full": "DE KLUIS",
"legal_form": "besloten vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition van het proces-verbaal van fusie"
],
"shareholders_after": [],
"share_classes_after": []
}02-05-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-05-02",
"filing_date": null,
"act_kind_objet": "MEDEDELING - NEERLEGGING VAN EEN FUSIEVOORSTEL"
},
"decision": {
"body": null,
"act_date": "2025-01-30",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0414.029.157",
"name": "APOTHEEK ERIKA JORIS",
"role": "absorbed",
"address": "Mechelseplein 20 - 2000 Antwerpen",
"is_foreign": false,
"legal_form": "BV",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0462.891.621",
"name": "DE KLUIS",
"role": "acquiring",
"address": "Mechelseplein 20 - 2000 Antwerpen",
"is_foreign": false,
"legal_form": "BV",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"12:58"
],
"is_cross_border": false,
"is_silent_merger": true,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": true,
"patrimony_description": "APOTHEEK ERIKA JORIS draagt haar gehele vermogen, zowel activa als passiva, over aan DE KLUIS.",
"equity_transferred_eur": null,
"accounting_effective_date": "2025-01-01"
},
"subject_company": {
"kbo": "0462.891.621",
"name_full": "De Kluis",
"legal_form": "Besloten Vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0475.026.024",
"org_name": "Accounting \u0026 Tax Partners nv",
"person_name": null,
"org_rep_person_name": "Gunther Eerdekens"
},
"summary_narrative": "De bestuursorganen van APOTHEEK ERIKA JORIS BV en DE KLUIS BV hebben gezamenlijk een fusievoorstel opgesteld. Het voorstel voorziet in de overname van APOTHEEK ERIKA JORIS door DE KLUIS via een met een fusie door overneming gelijkgestelde verrichting. Omdat DE KLUIS de enige aandeelhouder van APOTHEEK ERIKA JORIS is, is de overgenomen vennootschap te ontbinden zonder vereffening en overdraagt haar gehele vermogen aan DE KLUIS.",
"co_filed_documents": [],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}| Legal nameNL | DE KLUIS |